Evidence map›Paper›PMID 32861887›Full record

ArticleHeart & lung : the journal of critical care

Surviving 2019 novel coronavirus pneumonia: A successful critical case report.

Lei Zou, Jiakui Sun, Ying Liu, Wenhao Zhang, Wei Jiang, Shoutao Yuan, Qiankun Shi

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Heart & lung : the journal of critical care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 1 citations in OpenAlex.

  1. Pooled it
  2. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lei ZouDepartment of Critical Care Medicine, Nanjing First Hospital, Nanjing, Jiangsu Province, China. Electronic address: zoulei06123@163.com.
Jiakui SunDepartment of Critical Care Medicine, Nanjing First Hospital, Nanjing, Jiangsu Province, China.
Ying LiuDepartment of Critical Care Medicine, Nanjing First Hospital, Nanjing, Jiangsu Province, China.
Wenhao ZhangDepartment of Critical Care Medicine, Nanjing First Hospital, Nanjing, Jiangsu Province, China.
Wei JiangTongji Hospital, Wuhan, Hubei Province, China.
Shoutao YuanDepartment of Critical Care Medicine, Nanjing First Hospital, Nanjing, Jiangsu Province, China.
Qiankun ShiDepartment of Critical Care Medicine, Nanjing First Hospital, Nanjing, Jiangsu Province, China.
Jiangsu Province Hospital · CNTongji Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background. An outbreak of acute respiratory illness was proved to be infected by a novel coronavirus, officially named Coronavirus Disease 2019 (COVID-19) from World Health Organization (WHO), was confirmed first in Wuhan, China, and has become endemic worldwide, which was a serious threaten to public health all over the world. Herein, we reported a successful critical case of COVID-19 and shared our experience of treatment, which would do a favor for other COVID-19 patients. CASE SUMMARY: . A 65-year-old man, Wuhan citizen, was infected by COVID-19, and his pulmonary lesions progressed quickly in five days. On admission to Tongji Hospital, Wuhan, China, the immediate arterial blood gas(ABG) analysis showed the PaO2/FiO2(P/F) ratio was 134.4mmHg, moderate acute respiratory distress syndrome(ARDS) was diagnosed. Emergency tracheal intubation was performed, and the initial ventilator mode and parameters were set up based on the lung-protective ventilation strategy, but the P/F ratio could not be improved, and then the prone position ventilation was carried out for four consecutive days, as long as 16 hours every day, the P/F ratio rose to 180mmHg approximately, which still did not reach to the standard of extubation. And then we found that it was complicated with acute cor pulmonale(ACP) by ultrasound examination, dobutamine and diuretic were used for the treatment of ACP caused by ARDS successfully, and the P/F ratio went up to about 250mmHg. Seven days later after admission, the endotracheal intubation was successfully removed, after extubation, High-Flow nasal cannula(HFNC) oxygen therapy was used as a sequential strategy to prevent reintubation. Ultimately, he was discharged on day 34 after admission.

conclusion. Our case presented the treatment process of a critical COVID-19. Effective therapy was crucial to heal COVID-19, and organ function support therapy, especially the cardiorespiratory function support therapy, was the core of treatment.

Indexed as

AgedBetacoronavirusBlood Gas AnalysisCoronavirus InfectionsCOVID-19HumansIntubation, IntratrachealMaleOxygen Inhalation TherapyPandemicsPneumonia, ViralSARS-CoV-2ACPARDSCOVID-19Prone position ventilation

Identifiers

PMID32861887
PMCPMC7440228
OpenAlexW3071873696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.